Why Is Conduit Pharmaceuticals (CDT) Stock Up 73% Today?

On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines. Conduit Pharmaceuticals (NASDAQ:CDT) stock is taking off on Tuesday alongside a new patent for the clinical-stage specialty biopharmaceutical company. Conduit Pharmaceuticals notes that it now has an Austrailian patent that covers its HK-4 Glucok ...